<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05044416</url>
  </required_header>
  <id_info>
    <org_study_id>VieScOP-II</org_study_id>
    <nct_id>NCT05044416</nct_id>
  </id_info>
  <brief_title>VieScope in Patients With an Expected Difficult Airway</brief_title>
  <official_title>Tracheal Intubation With VieScope Versus Videolaryngoscopy in Patients for Elective Surgery With an Expected Difficult Airway - a Prospective Randomized Trial (VieScOP-II)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients requiring endotracheal intubation for elective surgery with an expected difficult&#xD;
      airway are randomized to be intubated either by a) VieScope or b) videolaryngoscopy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tracheal intubation is required for different surgical procedures for mechanical ventilation&#xD;
      and to prevent aspiration of secretions. In patients with an expected difficult airway,&#xD;
      tracheal intubation is often performed by videolaryngoscopy (VL). However, this technique has&#xD;
      limitations and may fail due to insufficient visualization of the larynx. A new device has&#xD;
      been introduced that consists of an illuminated straight plastic tube for laryngoscopy (VSC,&#xD;
      Vie Scope, Adroit Surgical, Oklahoma City, OK, USA) that enables for indirect intubation over&#xD;
      a stylet.&#xD;
&#xD;
      So far, the VSC has shown promising results in manikin studies for intubation in normal and&#xD;
      difficult airways. We aim to test the VSC in patients compared to videolaryngoscopy in a&#xD;
      prospective randomized non-inferiority trial.&#xD;
&#xD;
      Patients will be assessed for eligibility in the Anesthesiology Pre-assessment Clinic of the&#xD;
      University Medical Center Hamburg-Eppendorf prior to elective surgery. All patients receive a&#xD;
      structured preoperative airway assessment.&#xD;
&#xD;
      Patients are randomized 1:1 to either intervention or control group. Patients randomized to&#xD;
      the intervention group will be intubated with the VSC. Patients randomized to the control&#xD;
      group are intubated with a MacIntosh type videolaryngoscope (CMAC, Storz, Germany).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 15, 2021</start_date>
  <completion_date type="Anticipated">August 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized 1:1</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>device for intubation may not be blinded for provider or investigator</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>POGO</measure>
    <time_frame>15 min</time_frame>
    <description>intubating conditions according to the percentage of glottis opening score (POGO)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>first attempt success rate</measure>
    <time_frame>15 min</time_frame>
    <description>percentage of successful intubations with one attempt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to intubation</measure>
    <time_frame>15 min</time_frame>
    <description>time until tracheal airway access is established</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cormack-Lehane</measure>
    <time_frame>15 min</time_frame>
    <description>intubating conditions according to Cormack-Lehane</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>overall success rate</measure>
    <time_frame>15 min</time_frame>
    <description>percentage of successful intubations with the allocated procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to successful intubation with one attempt</measure>
    <time_frame>15 min</time_frame>
    <description>time until tracheal airway access is established in patients that are intubated at first attempt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intubation difficulty</measure>
    <time_frame>15 min</time_frame>
    <description>subjective rating on a visual analogue scale (0-100, higher values indicate more difficult intubation) of the difficulty of airway management and questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of attempts</measure>
    <time_frame>15 min</time_frame>
    <description>total number of attempts until airway established</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>aspiration</measure>
    <time_frame>15 min</time_frame>
    <description>percentage of patients that vomit and aspirate during intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>esophageal intubation</measure>
    <time_frame>15 min</time_frame>
    <description>percentage of accidental esophageal intubation attempts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hypoxia</measure>
    <time_frame>15 min</time_frame>
    <description>percentage of patients with a desaturation below a pulsoximetric saturation of 80%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hypotension</measure>
    <time_frame>15 min</time_frame>
    <description>percentage of patients with a systolic blood pressure below 70 mmHg</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">58</enrollment>
  <condition>Airway Management</condition>
  <arm_group>
    <arm_group_label>VieScope</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intubation with the VieScope laryngoscope</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Videolaryngoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intubation with videolaryngoscope</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VieScope</intervention_name>
    <description>intubation with VieScope laryngoscope</description>
    <arm_group_label>VieScope</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Videolaryngoscopy</intervention_name>
    <description>intubation with videolaryngoscope</description>
    <arm_group_label>Videolaryngoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients requiring general anesthesia with transoral tracheal intubation for elective&#xD;
             surgery&#xD;
&#xD;
          -  Age ≥ 18&#xD;
&#xD;
          -  Preoperative airway assessment reveals an expected difficult airway (rated by the&#xD;
             responsible anesthetist in the Pre-assessment Clinic based on the existing in-house&#xD;
             algorithm)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or breastfeeding woman&#xD;
&#xD;
          -  Confirmed indications for awake fiberoptic intubation especially due to enoral,&#xD;
             pharyngeal tumors, abscesses or other processes&#xD;
&#xD;
          -  Planned endotracheal intubation without deep anesthesia or neuromuscular blocking&#xD;
             agents (e.g. awake videolaryngoscopy)&#xD;
&#xD;
          -  Required transnasal tracheal intubation (e.g. for surgical reasons)&#xD;
&#xD;
          -  Requirement of special endotracheal tubes such as laser or RAE tubes for surgical&#xD;
             reasons&#xD;
&#xD;
          -  Patients at risk for pulmonary aspiration who qualify for rapid sequence induction&#xD;
&#xD;
          -  Loose teeth&#xD;
&#xD;
          -  Denial of consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joern Grensemann, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martin Petzoldt, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joern Grensemann, MD</last_name>
    <phone>+49 152 228 24247</phone>
    <email>j.grensemann@uke.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Martin Petzoldt, MD</last_name>
    <email>m.petzoldt@uke.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <state>HH</state>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 5, 2021</study_first_submitted>
  <study_first_submitted_qc>September 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2021</study_first_posted>
  <last_update_submitted>September 5, 2021</last_update_submitted>
  <last_update_submitted_qc>September 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

